On this episode Lara and Vyanka talk to Dr Aonghus Lavelle all about the microbiomes of the human body. This is ImmunoTea: Your Immunology Podcast, presented by Dr Lara Dungan and Dr Vyanka Redenbaugh. This is the show where we tell you all about the most exciting research going on in the world of immunology. So grab a cup of tea, sit down and relax and we'll fill you in. Contact us at ImmunoTeaPodcast@gmail.com or @ImmunoTea on twitter. Hosted on Acast. See acast.com/privacy for more information.

On this episode Lara and Vyanka talk to Prof Emma Morris all about stem cell transplantation and gene editing for inborn errors of immunity. This is ImmunoTea: Your Immunology Podcast, presented by Dr Lara Dungan and Dr Vyanka Redenbaugh. This is the show where we tell you all about the most exciting research going on in the world of immunology. So grab a cup of tea, sit down and relax and we'll fill you in. Contact us at ImmunoTeaPodcast@gmail.com or @ImmunoTea on twitter. Hosted on Acast. See acast.com/privacy for more information.

In this engaging conversation, Prof. Jonathan Hourihane, a leading authority on pediatric peanut allergy and immunotherapy, dives into the complexities of Type 1 hypersensitivity reactions. He discusses groundbreaking strategies for managing peanut allergies, including the impact of early allergen exposure. The dialogue highlights oral and epicutaneous immunotherapy, revealing pivotal clinical trials like the Artemis trial. Prof. Hourihane also shares insights on future innovations and the need for proactive public health guidelines to enhance treatment outcomes for children.

In this fascinating discussion, distinguished immunologist Prof. Kingston Mills and neurological autoimmunity expert Dr. Anastasia Zekeridou dive deep into the powerful cytokine IL-17. They unpack its dual role in diseases like multiple sclerosis, emphasizing targeted therapies and potential risks of blocking IL-17. The guests also touch on the role of tissue-resident memory T cells and the implications of immune responses in paraneoplastic neurological syndromes. Their insights on antibody pathogenicity and the intersection of cancer treatment with neurological autoimmunity are truly enlightening.